Watch for Zelnorm's Return for Irritable Bowel Syndrome With Constipation
Zelnorm (tegaserod) will be back on your pharmacy shelves to treat irritable bowel syndrome with constipation (IBS-C) in women.
It was first approved in 2002...then taken off the market in 2007 due to reports of heart attack, stroke, and unstable angina.
Since then, it's been available on a case-by-case basis from various manufacturers.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote